Nasal spray aims to ease heart failure symptoms in new study
NCT ID NCT07375212
First seen Jan 30, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study was designed to see if a single dose of bumetanide nasal spray can quickly reduce fluid and blood pressure in the lungs for people with heart failure. Participants would have had an implanted monitoring device and mild congestion. The study was withdrawn before enrolling anyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE, CONGESTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prisma Health
Greenville, South Carolina, 29605, United States
Conditions
Explore the condition pages connected to this study.